Name | 4-(4-chlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid |
---|---|
Synonyms |
4-(4-Chlorophenyl)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarboxylic acid
1,4-Piperidinedicarboxylic acid, 4-(4-chlorophenyl)-, 1-(1,1-dimethylethyl) ester |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 471.3±45.0 °C at 760 mmHg |
Molecular Formula | C17H22ClNO4 |
Molecular Weight | 339.814 |
Flash Point | 238.9±28.7 °C |
Exact Mass | 339.123749 |
PSA | 66.84000 |
LogP | 3.30 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.552 |
Hazard Codes | Xn |
---|---|
HS Code | 2933399090 |
~88% 644981-94-2 |
Literature: Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Harriman, Geraldine C.B.; Carson, Kenneth G.; Ghosh, Shomir; Elder, Amy M.; Mattia, Karen M. Patent: US2005/70549 A1, 2005 ; |
~45% 644981-94-2 |
Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2007/125321 A2, 2007 ; Location in patent: Page/Page column 132 ; WO 2007/125321 A2 |
~45% 644981-94-2 |
Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/51290 A2, 2006 ; Location in patent: Page/Page column 147 ; WO 2006/051290 A2 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |